Walleye Capital LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$14.37 - $19.07 $4.7 Million - $6.24 Million	327,332 New	327,332 $5.74 Million
Q4 2022 Feb 14, 2023	SELL	$11.42 - $17.05 $2 Million - $2.98 Million	-175,018 Reduced 78.4%	48,217 $722,000
Q3 2022 Nov 14, 2022	SELL	$9.76 - $13.41 $709,434 - $974,746	-72,688 Reduced 24.56%	223,235 $2.87 Million
Q2 2022 Aug 08, 2022	BUY	$7.6 - $11.41 $1.48 Million - $2.22 Million	194,313 Added 191.23%	295,923 $2.87 Million
Q1 2022 May 16, 2022	BUY	$9.3 - $12.37 $169,687 - $225,703	18,246 Added 21.89%	101,610 $1.01 Million
Q4 2021 Mar 03, 2022	BUY	$10.39 - $15.15 $866,151 - $1.26 Million	83,364 New	83,364 $981,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.